BIOY vs. CWII
BIOY (GraniteShares YieldBOOST Biotech ETF) and CWII (REX CRWV Growth & Income ETF) are both Derivative Income funds. Both are actively managed. At a 0.17 correlation, their price movements are largely independent. BIOY charges 1.07%/yr vs 1.03%/yr for CWII.
Performance
BIOY vs. CWII - Performance Comparison
Loading charts...
Returns By Period
BIOY
- 1D
- -3.35%
- 1M
- -2.48%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
CWII
- 1D
- —
- 1M
- —
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- —
BIOY vs. CWII - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
BIOY GraniteShares YieldBOOST Biotech ETF | -3.36% |
CWII REX CRWV Growth & Income ETF | 8,850.89% |
Correlation
The correlation between BIOY and CWII is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since May 5, 2026 | 0.17 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIOY vs. CWII - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for GraniteShares YieldBOOST Biotech ETF (BIOY) and REX CRWV Growth & Income ETF (CWII). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Drawdowns
BIOY vs. CWII - Drawdown Comparison
Loading charts...
Drawdown Indicators
| BIOY | CWII | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -6.64% | — | — |
Current DrawdownCurrent decline from peak | -6.64% | — | — |
Average DrawdownAverage peak-to-trough decline | -2.16% | — | — |
Volatility
BIOY vs. CWII - Volatility Comparison
Loading charts...
Volatility by Period
| BIOY | CWII | Difference | |
|---|---|---|---|
Volatility (1Y)Calculated over the trailing 1-year period | 18.55% | — | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.55% | — | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.55% | — | — |
BIOY vs. CWII - Expense Ratio Comparison
BIOY has a 1.07% expense ratio, which is higher than CWII's 1.03% expense ratio.
Dividends
BIOY vs. CWII - Dividend Comparison
BIOY's dividend yield for the trailing twelve months is around 13.82%, while CWII has not paid dividends to shareholders.
| Position | TTM | 2025 |
|---|---|---|
BIOY GraniteShares YieldBOOST Biotech ETF | 13.82% | 0.00% |
CWII REX CRWV Growth & Income ETF | 123.26% | 6.09% |
Frequently Asked Questions
BIOY and CWII have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CWII is cheaper at 1.03% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CWII is cheaper with a 1.03% expense ratio, compared with 1.07% for BIOY.
CWII has the higher dividend yield at 123.26%, compared with 13.82% for BIOY.
They also come from different issuers: GraniteShares and REX Shares. Their fees differ too: 1.07% for BIOY and 1.03% for CWII.
Find the right allocation for BIOY and CWII
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer